KBP-336

N/A

Report date: 2025/03/12 15:44:55
NME

Base Information

Drug NameKBP-336
Drug Alias NameKBP-336
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCalcitonin receptor agonistsAmylin receptor agonists
TargetsCalcitonin receptorAmylin Receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Osteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaPolandRomania +[6
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKeybioscience Ag
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2Osteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A